Delivery Order SPE2DB22D9353-SPE2DB25FX2DM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,154.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, carries no set-aside designation. The award represents a continuation of DMS Pharmaceutical Group's role as a critical supplier...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, represents a tactical purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500...
- The Defense Logistics Agency awarded a $48,749.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract was awarded on June 18, 2025, with an ultimate completion date of July 11, 2025, and carries no set-aside designation. This delivery order represents a single pharmaceutical product fulfillment under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $32,499.90 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, is set to be completed by October 9, 2025, and will be performed at the contractor's Park Ridge facility. The award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite...
- On July 10, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $48,750 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for Stelara 90 mg/mL syringes, a biologic immunosuppressant medication, with an ultimate completion date of July 31, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on July 17, 2025. The contract calls for delivery of Stelara 90 mg/ml syringes, a biologic medication used to treat immunological conditions, with an ultimate completion date of August 7, 2025. This delivery order carries no set-aside designation and will be performed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency on September 5, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents one of many pharmaceutical product deliveries issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a $48,749.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, awarded on June 30, 2025, with an ultimate completion date of July 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of September 9, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, designated as a firm fixed-price delivery order, was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2DMDelivery Order
On August 26, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $48,750 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for Stelara 90 mg/ml syringes, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order was issued without set-aside designation and represents one of numerous pharmaceutical supply orders DMS Pharmaceutical Group fulfills for the DLA's military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million and valid through November 2026 under the SPE2DB program. Through this comprehensive IDC vehicle, the company supplies an extensive portfolio of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently leveraging its woman-owned small business status to secure contracts for specialized medications and medical supplies supporting military health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.7k | 8/26/25 |